PBH

NYSE · Pharmaceuticals

Prestige Consumer Healthcare

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$47.73

+0.93 (+1.99%)

As of Sep 22, 9:58 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +63.7% upside

Low Target $50.25

Average Target $78.15

High Target $108.25

Current Price $47.73

Current
$47.73

Target
$78.15

$50.25 $78.15 avg $108.25

Scenario Analysis

Bear Case

$50.25

5.3%

Low target

Base Case

$78.15

+63.7%

Avg target

Bull Case

$108.25

+126.8%

High target

Risk/Reward

24.0x

Highly favorable

Price in Context

52-Week High

$71.07

-32.8% from high

52-Week Low

$42.62

+12.0% from low

50-Day SMA

$64.04

-25.5% vs SMA

200-Day SMA

$69.15

-31.0% vs SMA

RSI (14)

68.6

Neutral

Target vs 52W High

$78.15

+10.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%